Preclinical data support remyelinating potential of ABX-002
ABX-002, an experimental treatment for multiple sclerosis (MS) being developed by Autobahn Therapeutics, promoted the restoration of the myelin sheath in preclinical models of the disease, new data show. The research, which specifically tested an analog of ABX-002 called LL-341070, will be presented by Autobahn’s academic collaborators at a pair of conferences this summer. “We are excited to […]
Funding opportunity
MSNZ is delighted with the announcement from the New Zealand MS Research Trust that they have received funding of NZ$150,000 a year for three years to support neurologists who wish to travel overseas to specialise in the treatment of people with multiple sclerosis. This may take in the form of a fellowship for a registrar […]
Evaluating health literacy in individuals with a neurological condition and caregivers
Are you living with a neurological condition? Do you support someone living with a neurological condition? Are you interested in undertaking a survey on health and e-health literacy (the ability to find, understand, and use online and offline health information)? This study is observational and will provide us with information needed to develop novel health […]
Neurology Research Review
The latest edition of Neurology Research Review is out now and has a special focus on MS. Neurology_Research_Review_Issue_77
Recording available – Progressive MS Treatment and Research
Learn about the latest advances in progressive MS research and treatment during this 30-minute International Progressive MS Alliance webcast. An international panel of MS experts will answer questions submitted by people affected by MS from throughout the world. From symptom management and well-being to the development of treatments that can slow progression and rebuild myelin, […]
Can you spare 10 minutes to help us capture the impact of the MS Brain Health initiative?
MS Brain Health are running a survey to capture the value of their work on individuals in developing their approach to MS care – both in terms of personal impact and the wider health and care environment. If you are aware of the project and feel it has had an impact on MS care, then […]
COVID-19 and MS – Global Data Sharing Initiative
MS data sharing during the coronavirus pandemic The MS Data Alliance (MSDA) and the MS International Federation (MSIF) with its members, have teamed up to lead a global data sharing initiative for COVID-19 in people with MS. They are calling on individuals and organisations across the global MS movement to get involved. Multiple Sclerosis New […]
The Good Service Project
“Is it reasonable to wait four months for my neurology referral or MRI?” It’s a surprisingly common question, and that worries us. We regularly receive calls from distressed people experiencing multiple sclerosis (MS) symptoms for the first time or in the throes of relapse. These people often feel helpless to speed up the medical attention […]
The Cost of MS Study
New Zealanders with multiple sclerosis (MS) face undue restrictions to life-altering drug treatments and valuable social supports. The cost and consequences of this lack of access are enormous. We believe this needs to change. New Zealanders with MS need better access to these critical treatments and supports. For example, studies show that the speed of […]